DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 77.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2012Validity of the Fear of Progression Questionnaire- Short Form in patients with Systemic SclerosisKwakkenbos, C.M.C.; Hoogen, F.H.J. van den; Custers, J.A.E.; Prins, J.B.; Vonk, M.C.; Lankveld, W.G.J.M. van; Becker, E.S.; Ende, C.H.M. van den
2012Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteemKwakkenbos, C.M.C.; Lankveld, W.G.J.M. van; Vonk, M.C.; Becker, E.S.; Hoogen, F.H.J. van den; Ende, C.H.M. van den
2011Determinants of Depressive Symptoms in Patients with Systemic Sclerosis, Including Fear of Progression and Appearance Self EsteemKwakkenbos, C.M.C.; Lankveld, W.G.J.M. van; Vonk, M.C.; Becker, E.S.; Hoogen, F.H.J. van den; Ende, C.H.M. van den
2010Poor psychological health status among patients with inflammatory rheumatic diseases and osteoarthritis in multidisciplinary rehabilitation: need for a routine psychological assessment.Vriezekolk, J.; Eijsbouts, A.; Evers, A.W.M.; Stenger, A.; Hoogen, F.H.J. van den; Lankveld, W.G.J.M. van
2010Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress.Harardottir, H.; Helvoort, H.A.C. van; Vonk, M.C.; Hoogen, F.H.J. van den; Dekhuijzen, P.N.R.; Heijdra, Y.F.
2010Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.Avouac, J.; Walker, U.; Tyndall, A.; Kahan, A.; Matucci-Cerinic, M.; Allanore, Y.; Miniati, I.; Müller, A.; Iannone, F.; Distler, O.; Becvar, R.; Sierakowsky, S.; Kowal-Bielecka, O.; Coelho, P.C.; Cabane, J.; Cutolo, M.; Shoenfeld, Y.; Valentini, G.; Rovensky, J.; Riemekasten, G.; Vlachoyiannopoulos, P.G.; Caporali, R.; Jiri, S.; Inanc, M.; Zimmermann Gorska, I.; Carreira, P.; Novak, S.; Czirjak, L.; Oliveira Ramos, F.; Jendro, M.; Chizzolini, C.; Kucharz, E.J.; Richter, J.; Cozzi, F.; Rozman, B.; Mallia, C.M.; Gabrielli, A.; Farge, D.; Kiener, H.; Schoffel, D.; Airo, P.; Wollheim, F.; Martinovic, D.; Trotta, F.; Jablonska, S.; Reich, K.; Bombardieri, S.; Siakka, P.; Pellerito, R.; Bambara, L.M.; Morovic-Vergles, J.; Denton, C.; Hinrichs, R.; Hoogen, F.H.J. van den; Damjanov, N.; Kotter, I.; Ortiz, V.; Heitmann, S.; Krasowska, D.; Seidel, M.; Hasler, P.; Laar, J.M. van; Kaltwasser, J.P.; Foeldvari, I.; Juan Mas, A.; Bajocchi, G.; Wislowska, M.; Pereira Da Silva, J.A.; Jacobsen, S.; Worm, M.H.J.B.; Graniger, W.; Kuhn, A.; Stankovic, A.; Cossutta, R.; Majdan, M.; Damjanovska Rajcevska, L.; Tikly, M.; Nasonov, E.L.; Steinbrink, K.; Herrick, A.; Muller-Ladner, U.; Dinc, A.; Scorza, R.; Sondergaard, K.; Indiveri, F.; Nielsen, H.; Szekanecz, Z.; Silver, R.M.; Antivalle, M.; Espinosa, I.B.; Garcia de la Pena Lefebvre, P.; Midtvedt, O.; Launay, D. de; Valesini, F.; Tuvik, P.; Vonk, M.C.
2010Analysis of 4-year Dutch reimbursement application data of biological therapies for psoriatic arthritis.Driessen, R.J.B.; Jong, E.M.G.J. de; Salemink, G.W.; Burer, J.H.G.; Kerkhof, P.C.M. van de; Hoogen, F.H.J. van den
2010Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).Alizadeh, B.Z.; Broen, J.; Rueda, B.; Hesselstrand, R.; Wuttge, D.; Simeon, C.; Ortego-Centeno, N.; Gonzalez-Gay, M.A.; Pros, A.; Herrick, A.; Worthington, J.; Denton, C.; Fonseca, C.; Riemekasten, G.; Vonk, M.C.; Hoogen, F.H.J. van den; Guiducci, S.; Matucci-Cerinic, M.; Scorza, R.; Beretta, L.; Airo, P.; Coenen, M.J.H.; Martin, J.; Koeleman, B.P.; Radstake, T.R.D.J.
2009Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjogren's syndrome patients.Zandbelt, M.; Boome, L. te; Klasen, I.S.; Putte, L.B.A. van de; Hoogen, F.H.J. van den
2009Fall incidence and fall risk factors in people with rheumatoid arthritis.Smulders, E.; Schreven, C.; Weerdesteijn, V.G.M.; Hoogen, F.H.J. van den; Laan, R.F.J.M.; Lankveld, W.G.J.M. van
2009Treatment of the inflammatory myopathies: update and practical recommendations.Hengstman, G.J.D.; Hoogen, F.H.J. van den; Engelen, B.G.M. van
2009The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients.Radstake, T.R.D.J.; Vonk, M.C.; Dekkers, M.; Schijvenaars, M.M.V.A.P.; Treppichio, W.L.; Lafyatis, R.; Riemekasten, G.; Hoogen, F.H.J. van den; Coenen, M.J.H.
2009Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study.Vonk, M.C.; Broers, B.; Heijdra, Y.F.; Ton, E.; Snijder, R.; Dijk, A.P.J. van; Laar, J.M. van; Bootsma, H.J.; Hal, P.T. van; Hoogen, F.H.J. van den; Daele, P.L. van
2009Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.Radstake, T.R.D.J.; Svenson, M.; Eijsbouts, A.M.M.; Hoogen, F.H.J. van den; Enevold, C.; Riel, P.L.C.M. van; Bendtzen, K.
2009Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.Bemt, B.J.F. van den; Hoogen, F.H.J. van den; Benraad, B.; Hekster, Y.A.; Riel, P.L.C.M. van; Lankveld, W.G.J.M. van
2009A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.Rueda, B.; Simeon, C.; Hesselstrand, R.; Herrick, A.; Worthington, J.; Ortego-Centeno, N.; Riemekasten, G.; Fonollosa, V.; Vonk, M.C.; Hoogen, F.H.J. van den; Sanchez-Roman, J.; Aguirre-Zamorano, M.A.; Garcia-Portales, R.; Pros, A.; Camps, M.T.; Gonzalez-Gay, M.A.; Gonzalez-Escribano, M.F.; Coenen, M.J.H.; Lambert, N.; Nelson, J.L.; Radstake, T.R.D.J.; Martin, J.
2009The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.Rueda, B.; Broen, J.; Torres, O.; Simeon, C.; Ortego-Centeno, N.; Schrijvenaars, M.M.; Vonk, M.C.; Fonollosa, V.; Hoogen, F.H.J. van den; Coenen, M.J.H.; Sanchez-Roman, J.; Aguirre-Zamorano, M.A.; Garcia-Portales, R.; Pros, A.; Camps, M.T.; Gonzalez-Gay, M.A.; Martin, J.; Radstake, T.R.D.J.
2009Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.Kroft, E.B.M.; Creemers, M.C.W.; Hoogen, F.H.J. van den; Boezeman, J.B.M.; Jong, E.M.G.J. de
2009Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.Popa, C.; Tits, L.J.H. van; Barrera Rico, P.; Lemmers, H.L.M.; Hoogen, F.H.J. van den; Riel, P.L.C.M. van; Radstake, T.R.D.J.; Netea, M.G.; Roest, M.; Stalenhoef, A.F.H.
2009Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.Popa, C.; Netea, M.G.; Graaf, J. de; Hoogen, F.H.J. van den; Radstake, T.R.D.J.; Toenhake-Dijkstra, H.I.; Riel, P.L.C.M. van; Meer, J.W.M. van der; Stalenhoef, A.F.H.; Barrera, P.
2009Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.Lieshout, A.W.T. van; Vonk, M.C.; Bredie, S.J.H.; Joosten, L.A.B.; Netea, M.G.; Riel, P.L.C.M. van; Lafyatis, R.; Hoogen, F.H.J. van den; Radstake, T.R.D.J.
2009Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers.Eijsbouts, A.M.M.; Kempers, M.J.E.; Kramer, R.S.; Hopman, M.T.E.; Hoogen, F.H.J. van den; Laan, R.F.J.M.; Hermus, A.R.M.M.; Sweep, C.G.J.; Putte, L.B.A. van de
2009The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.Rueda, B.; Broen, J.; Simeon, C.; Hesselstrand, R.; Diaz, B.; Suarez, H.; Ortego-Centeno, N.; Riemekasten, G.; Fonollosa, V.; Vonk, M.C.; Hoogen, F.H.J. van den; Sanchez-Roman, J.; Aguirre-Zamorano, M.A.; Garcia-Portales, R.; Pros, A.; Camps, M.T.; Gonzalez-Gay, M.A.; Coenen, M.J.H.; Airo, P.; Beretta, L.; Scorza, R.; Laar, J. van; Gonzalez-Escribano, M.F.; Nelson, J.L.; Radstake, T.R.D.J.; Martin, J.
2008Social support, disease-related cognitions and coping as predictors of depressed mood in systemic sclerosisLankveld, W.G.J.M. van; Teunissen, H.A.; Näring, G.W.B.; Vonk, M.C.; Hoogen, F.H.J. van den
2008Social support, disease-related cognitions and coping as predictors of depressed mood in systemic sclerosisLankveld, W.G.J.M. van; Teunissen, H.; Näring, H.; Vonk, M.C.; Hoogen, F.H.J. van den
2008Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma.Vonk, M.C.; Die, CE van; Snoeren, M.M.; Bhansing, K.J.; Riel, P.L.C.M. van; Fransen, J.; Hoogen, F.H.J. van den
2008Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.Bemt, B.J. van den; Broeder, AA den; Snijders, G.F.; Hekster, Y.A.; Riel, P.L.C.M. van; Benraad, B.; Wolbink, G.J.; Hoogen, F.H.J. van den
2008Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.Vonk, M.C.; Marjanovic, Z.; Hoogen, F.H.J. van den; Zohar, S.; Schattenberg, A.V.M.B.; Fibbe, W.E.; Larghero, J.; Gluckman, E.; Preijers, F.W.; Dijk, A.P. van; Bax, J.J.; Roblot, P.; Riel, P.L.C.M. van; Laar, J.M. van; Farge, D.
2007What does the clinician need to improve patient care in systemic sclerosis?Vonk, M.C.; Hoogen, F.H.J. van den; Riel, P.L.C.M. van; Valentini, G.
2007Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.Huvers, F.C.; Popa, C.; Netea, M.G.; Hoogen, F.H.J. van den; Tack, C.J.J.
2007Appearance self-esteem in systemic sclerosis--subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables.Lankveld, W.G.J.M. van; Vonk, M.C.; Teunissen, H.; Hoogen, F.H.J. van den
2007Survivorship of the KUDO total elbow prosthesis--comparative study of cemented and uncemented ulnar components: 89 cases followed for an average of 6 years.Heide, H.J. van der; Vos, M.J. de; Brinkman, J.M.; Eygendaal, D.; Hoogen, F.H.J. van den; Waal Malefijt, M.C. de
2007Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis.Lieshout, A.W.T. van; Fransen, J.; Flendrie, M.; Eijsbouts, A.M.M.; Hoogen, F.H.J. van den; Riel, P.L.C.M. van; Radstake, T.R.D.J.
2007Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases.Vonk, M.C.; Sander, M.; Hoogen, F.H.J. van den; Riel, P.L.C.M. van; Verheugt, F.W.A.; Dijk, A.P.J. van
2007Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.Radstake, T.R.D.J.; Fransen, J.; Toonen, E.J.M.; Coenen, M.J.H.; Eijsbouts, A.E.; Donn, R.; Hoogen, F.H.J. van den; Riel, P.L.C.M. van
2007Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.Popa, C.; Hoogen, F.H.J. van den; Radstake, T.R.D.J.; Netea, M.G.; Eijsbouts, A.E.; Heijer, M. den; Heijer, M. den; Meer, J.W.M. van der; Riel, P.L.C.M. van; Stalenhoef, A.F.H.; Barrera, P.
2007Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study.Broeder, A. den; Creemers, M.C.W.; Fransen, J.; Jong, E. de; Rooij, D.J.R.A.M. de; Wymenga, A.B.; Waal Malefijt, M.C. de; Hoogen, F.H.J. van den
2006InforMatrix: treatment of rheumatoid arthritis using biologicals.Bemt, B.J. van den; Hoogen, F.H.J. van den; Breedveld, F.C.; Tempel, H. van der; Janknegt, R.
2006[Treatment of systemic sclerosis.]Hoogen, F.H.J. van den
2006Eosinophilic fasciitis in a child mimicking a myopathy.Pillen, S.; Engelen, B.G.M. van; Hoogen, F.H.J. van den; Fiselier, T.J.W.; Vossen, P. van der; Drost, G.
2006Disease related use of the internet in chronically ill adults: current and expected use.Lankveld, W.G.J.M. van; Derks, A.M.; Hoogen, F.H.J. van den
2006Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.Zandbelt, M.; Houbiers, J.G.A.; Hoogen, F.H.J. van den; Meijerink, J.; Riel, P.L.C.M. van; Hout, J. in't; Putte, L.B.A. van de
2006Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.Broeder, A. den; Jong, E. de; Franssen, M.J.A.M.; Jeurissen, M.E.; Flendrie, M.; Hoogen, F.H.J. van den
2005Vier vernieuwingen in de CBO richtlijn myositis.Jennekens, F.G.I.; Hoogendijk, J.E.; Engelen, B.G.M. van; Coo, I.F.M. de; Hoogen, F.H.J. van den; Visser, M. de
2005Pulmonary hypertension: its diagnosis and management, a multidisciplinary approach.Vonk, M.C.; Dijk, A.P.J. van; Heijdra, Y.F.; Heijden, E. van der; Bredie, S.J.H.; Hoogen, F.H.J. van den
2005Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease.Hof, D.; Cheung, K.; Rooij, D.J.R.A.M. de; Hoogen, F.H.J. van den; Pruijn, G.J.M.; Venrooij, W.J.W. van; Raats, J.M.H.
2005Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity.Eijsbouts, A.M.M.; Hoogen, F.H.J. van den; Laan, R.F.J.M.; Sweep, C.G.J.; Hermus, A.R.M.M.; Putte, L.B.A. van de
2005Mortality in systemic sclerosis: an international meta-analysis of individual patient data.Ioannidis, J.P.; Vlachoyiannopoulos, P.G.; Haidich, A.B.; Medsger, T.A.; Lucas, M.; Michet, C.J.; Kuwana, M.; Yasuoka, H.; Hoogen, F.H.J. van den; Boome, L.C. te; Laar, J.M. van; Verbeet, N.L.; Matucci-Cerinic, M.; Georgountzos, A.; Moutsopoulos, H.M.
2005Autologous hematopoietic stem cell transplantation for autoimmune diseases.Gratwohl, A.; Passweg, J.R.; Bocelli-Tyndall, C.; Fassas, A.; Laar, J.M. van; Farge, D.; Andolina, M.; Arnold, R.; Carreras, E.; Finke, J.; Kotter, I.; Kozak, T.; Lisukov, I.; Lowenberg, B.; Marmont, A.; Moore, J.; Saccardi, R.; Snowden, J.A.; Hoogen, F.H.J. van den; Wulffraat, N.M.; Zhao, X.; Tyndall, A.
2005Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.Eijsbouts, A.M.M.; Hoogen, F.H.J. van den; Laan, R.F.J.M.; Hermus, A.R.M.M.; Sweep, C.G.J.; Putte, L.B.A. van de

1 2 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback